• Search results for COVAXIN
Image Title
covaxin-1603676480

AIIMS Delhi starts screening children aged 6 to 12 for clinical trials of Covaxin

AIIMS Patna, Mysore Medical College and Research Institute in Karnataka have also been selected to conduct clinical trials on children

Published on 14th June 2021
vaccine

Bharat Biotech Chairman and MD discuss Covaxin status with Vice-President 

During the interaction, the Vice-President lauded the collaboration between the ICMR and Bharat Biotech and stressed the importance of public-private partnership

Published on 25th December 2020
COVID_Vaccine_PTI

Bharat Biotech cuts Covaxin price for states to Rs 400 after widespread criticism

This follows a widespread criticism of its pricing policy as it sold Covaxin to the central government at Rs 150 per dose

Published on 29th April 2021
vaccine

Bharat Biotech recruits 13,000 volunteers for Covaxin Phase III trials

The Phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers across India

Published on 22nd December 2020
covaxin-1603676480

Bharat Biotech seeks DCGI's approval to conduct trials of nasal COVID-19 vaccine

COVID-19 vaccines of Serum Institute of India's 'Covishield' and Bharat Biotech's 'Covaxin' were granted permission for restricted use in an emergency situation by the DCGI on January 3

Published on 8th January 2021
covaxin-1603676480

Bharat Biotech to release results of Phase 3 trials of Covaxin in July

This comes amid a raging debate on a recent pre-print study which said that while both Covaxin and Covishield showed a good immune response, Covishield produced more antibodies than Covaxin

Published on 10th June 2021
covaxin-1603676480

Covaxin batch initiated in March will only be ready for supply in June: Bharat Biotech

The manufacturing, testing, release and distribution of vaccines are complex and multi-factorial processes with hundreds of steps, requiring a diverse pool of human resources, the firm said

Published on 28th May 2021
covaxin-1603676480

Covaxin demonstrates interim clinical efficacy of 81 per cent

The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with the Indian Council of Medical Research (ICMR)

Published on 3rd March 2021
covaxin-1603676480

Covaxin effective against new, emerging COVID-19 variants, says study

The study was conducted in collaboration with the National Institute of Virology and the Indian Council of Medical Research

Published on 16th May 2021
covaxin-1603676480

Covaxin will soon be manufactured in Bengaluru too, Bharat Biotech seeks expansion

In April, Bharat Biotech had announced the expansion of its manufacturing capacity across multiple facilities in Hyderabad and Bengaluru to produce 700 million doses of Covaxin annually

Published on 30th June 2021
COVID_Vaccine_PTI

COVID-19 vaccination for people in 18-44 age group begins at some private hospitals 

Fortis Healthcare, in a statement, had said people in the 18-44 age group will be administered Covaxin for Rs 1,250, which will include the cost of vaccine and administration charges

Published on 1st May 2021
covid_vaccine

COVID-19 vaccine likely by end of this year or early next year: AIIMS Doctor

AIIMS Ethics Committee on Saturday gave its approval for conducting the human clinical trial of the indigenously developed COVID-19 vaccine candidate Covaxin

Published on 21st July 2020
Vaccine_RGGH_EPS

COVID-19: Andhra Pradesh government to vaccinate people in 18-45 age group by first week of October 

About 9 lakh doses of Covishield and Covaxin were kept ready before commencing vaccination for the 18-45 age group

Published on 24th August 2021
covid-19-vaccine

COVID-19: Those between 18 and 44 in Bengaluru can get vaccinated at major hospitals, med colleges from May 10

The statement said that the government has already placed orders for two crore doses of Covishield and one crore of Covaxin to vaccinate the estimated 3.26 crore people in this age group

Published on 9th May 2021
covaxin-1603676480

Delhi HC seeks Centre's stand on PIL against Covaxin trial on children aged two-18 years

Covaxin, which has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, is being used on adults

Published on 19th May 2021

Search results 1 - 15 of 124